Literature DB >> 21813396

Large regenerative nodules in a patient with Budd-Chiari syndrome after TIPS positioning while on the liver transplantation list diagnosed by Gd-EOB-DTPA MRI.

Matteo Renzulli1, Vincenzo Lucidi, Cristina Mosconi, Chiara Quarneti, Emanuela Giampalma, Rita Golfieri.   

Abstract

BACKGROUND: Large regenerative nodules (LRNs) are hyperplastic benign nodules most commonly associated with Budd-Chiari syndrome (BCS), caused by outflow obstruction of the hepatic veins or vena cava. To our knowledge, no cases of LRNs arising in BCS after transjugular intrahepatic portosystemic shunt (TIPS) positioning and detected by Gd-EOB-DTPA MRI have been reported in the literature.
METHODS: A 58-year-old woman with BCS, on the liver transplantation (LT) list, underwent a follow-up enhanced MRI. Two years earlier, a TIPS had been placed. In 2008, recurrent hepaticoencephalopathy resistant to medical treatment fulfilled the LT criteria for BCS treated with TIPS and the patient was therefore added to the LT list. CT performed before TIPS had not detected any hepatic lesions. CT performed six months after TIPS showed its complete patency but documented two indeterminate hypervascular liver lesions.
RESULTS: MRI performed with Gd-EOB-DTPA revealed additional hypervascular lesions with uptake and retention of the medium in the hepatobiliary phase, thus reflecting a benign behavior of hepatocellular composition. These MRI features were related to LRNs as confirmed by histopathologic analysis.
CONCLUSIONS: Gd-EOB-DTPA-enhanced MRI is potentially superior to standard imaging using gadolinium chelates or spiral CT, especially for the differential diagnosis of hypervascular lesions. Gd-EOB-DTPA MRI may become the imaging method of choice for evaluating LT list patients with BCS after TIPS placement.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21813396     DOI: 10.1016/s1499-3872(11)60075-1

Source DB:  PubMed          Journal:  Hepatobiliary Pancreat Dis Int


  3 in total

Review 1.  Morphological, dynamic and functional characteristics of liver pseudolesions and benign lesions.

Authors:  Matteo Renzulli; Nicolò Brandi; Giulia Argalia; Stefano Brocchi; Andrea Farolfi; Stefano Fanti; Rita Golfieri
Journal:  Radiol Med       Date:  2022-01-13       Impact factor: 3.469

2.  Hepatobiliary MR contrast agents are useful to diagnose hepatocellular carcinoma in patients with Budd-Chiari syndrome.

Authors:  Morgane Van Wettere; Luisa Paulatto; Lucas Raynaud; Onorina Bruno; Audrey Payancé; Aurélie Plessier; Pierre-Emmanuel Rautou; Valérie Paradis; Dominique Cazals-Hatem; Dominique Valla; Valérie Vilgrain; Maxime Ronot
Journal:  JHEP Rep       Date:  2020-03-09

3.  An overview of hepatocellular carcinoma with atypical enhancement pattern: spectrum of magnetic resonance imaging findings with pathologic correlation.

Authors:  Jelena Djokic Kovac; Aleksandar Ivanovic; Tamara Milovanovic; Marjan Micev; Francesco Alessandrino; Richard M Gore
Journal:  Radiol Oncol       Date:  2021-01-29       Impact factor: 2.991

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.